Top 20 genes with significantly decreased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Subjects:

Significant Lipids by Category- Tiers 1 and 2. by Keenan Elliott (17181211)

Subjects:

Significant lipids by category-Tiers 1, 2, and 3. by Keenan Elliott (17181211)

Subjects:

Comparison of the statistical significance between t-tests with C₁ = 40 and CTOT with C₁ = 32. by Wei Zhuang (146641)

Metabolites elevated significantly in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

Case of normal load changing. by Basem Abd-Elhamed Rashad (17781467)

Top 20 genes with significantly increased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

Venn Diagram of significant features, Tier 1, 2, and 3–18, 36 hpbm. by Keenan Elliott (17181211)

Subjects:

Venn Diagram of significant features, Tier 1 and 2–18, 24, 36 hpbm. by Keenan Elliott (17181211)

Subjects:

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Estimated short- and long-term cumulative changes in CRC incidence and CRC mortality attributable to screening, diagnosis, and treatment decreases in 2020 and 2021. by Joachim Worthington (8394213)

Subjects:

Case. by Seungyoon Paik (14659575)

Odds ratios (95% CI) for acute exacerbation of IBD per 1 °C daily average temperature <i>decrease</i> at the first quartile. by Yeong Chan Lee (8809223)

Subjects:

Impact of SARS‐CoV‐2 infection on T, B and NK cell numbers in patients compared with the control group (**** <i>P< 0</i>.<i>0001</i>). by Sam Alahyari (12645313)

Subjects:

Posttreatment facial, intraoral photographs, and radiographs of the case with premolar tooth extraction. by Lijuan Liu (136685)

Subjects:

Intraoperative facial and intraoral photographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

Subjects:

Pretreatment facial, intraoral photographs, and radiographs of the case with premolar tooth extraction. by Lijuan Liu (136685)

Subjects:

Minimum number of patients to detect a significant protective effect of a drug against BRAO-induced GCL thickness loss. by Thomas R. Shearer (9761486)